Results 21 to 30 of about 19,765 (240)
Myricitrin: A promising herbal therapy for periodontitis in immunosuppressed status
Saudi Dental Journal, 2023 Background: Periodontitis is a complex chronic inflammatory disease aggravated in immunosuppressed patients. However, adjuvant therapies can alleviate severe inflammation and slow down disease progression.
Heba A. Shawky, Marwa M. Essawy
doaj +1 more source
Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates
Journal of Osteoporosis, 2014 The objective of this study was to compare the disintegration times among Canadian-marketed brand (alendronate 70 mg, alendronate 70 mg plus vitamin D 5600 IU, and risedronate 35 mg) and generic (Novo-alendronate 70 mg and Apo-alendronate 70 mg) once ...
Wojciech P. Olszynski +2 more
doaj +1 more source
Orthopaedic Surgery, 2021 Objective To compare the preventive effects of teriparatide and alendronate on the progression of vertebral body collapse in postmenopausal single‐level Kümmell's disease (KD).
Peng‐guo Gou +8 more
doaj +1 more source
Esophageal ulcer and alendronate [PDF]
Sao Paulo Medical Journal, 1998 OBJECTIVE: To describe a case of esophageal ulcer associated with the use of alendronate. CASE REPORT: This is the fifth case ever described in the literature according to our bibliographic review. In our patient, the association between the drug and the esophageal lesions was masked by the presence of a hiatal hernia, potentially a cause of the ...
Angelo Paulo Ferrari Junior +1 more
openaire +3 more sources
Alendronate gastric ulcers [PDF]
Alimentary Pharmacology & Therapeutics, 1999 Background: It appears likely that drugs other than NSAIDs may cause ulcers and ulcer complications (e.g. potassium chloride). Alendronate (Fosamax) is used in the treatment and prevention of metabolic bone disease and has also been associated with severe oesophageal damage and stricture.
D Y, Graham, H M, Malaty
openaire +2 more sources
Hypoparathyroidism unmasked by alendronate [PDF]
Postgraduate Medical Journal, 2000 Abstract The case of an elderly woman is reported in whom alendronate, given for osteoporosis, led to severe hypocalcaemia a few days after starting the drug treatment. This was caused by the unmasking of previously unrecognised hypoparathyroidism.
A S, Kashyap, S, Kashyap
openaire +2 more sources
European Cells & MaterialsBackground: Fracture is a common skeletal disorder, and fracture healing is a complex biological process. The Wingless-Int-Integrated/beta-catenin (Wnt/β-catenin) signaling pathway plays an important role in bone formation and fracture healing.
ZW Sun, QL Zhu, JP Gong, YH Sui, XY Liu
doaj +1 more source
JBMR Plus, 2021 Increases in bone mineral density (BMD) with osteoporosis treatment are associated with reduced fracture risk. Increasing BMD is therefore a goal of osteoporosis therapy.
Felicia Cosman +11 more
doaj +1 more source
Pharmacokinetics of alendronate in a combined Alendronate/Vitamin D3 tablet in healthy volunteers using plasma and urine data [PDF]
Songklanakarin Journal of Science and Technology (SJST), 2013 Alendronate is indicated for treatment of a variety of bone metabolism disorders. In spite of quite low plasma concentrationsfollowing oral administration, pharmacokinetic study of alendronate based on plasma concentrations had normally been reported for
Chalitpon Na nakorn +3 more
doaj
Common osteoporosis drug associated with increased rates of depression and anxiety
Scientific Reports, 2021 Osteoporosis affects over 10 million Americans over 50. Bisphosphonate therapy, mainly alendronate, is amongst the most prescribed treatments for the disease.
Dro Keshishi +2 more
doaj +1 more source